(Q77809113)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9893620%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

review article

1 reference

title

Camptothecins: a review of their development and schedules of administration (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9893620%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9893620%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

J O'Leary

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9893620%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

publication date

1 September 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9893620%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Cancer

8 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9893620%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9893620%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9893620%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

page(s)

1500-1508

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9893620%20AND%20SRC:MED&resulttype=core&format=json

Plant Antitumor Agents. I. The Isolation and Structure of Camptothecin, a Novel Alkaloidal Leukemia and Tumor Inhibitor from Camptotheca acuminata1,2

8 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900229-9

7 January 2021

Camptothecin inhibits macromolecular synthesis in mammalian cells but not in isolated mitochondria or lE. coli

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900229-9

7 January 2021

Ribosome Formation is Blocked by Camptothecin, a Reversible Inhibitor of RNA Synthesis

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900229-9

7 January 2021

Intracellular degradation of HeLa and adenovirus type 2 DNA induced by camptothecin

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900229-9

7 January 2021

DNA topoisomerase I--targeted chemotherapy of human colon cancer in xenografts

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900229-9

7 January 2021

Phase I Study of Weekly Intravenous Infusions of CPT-11, a New Derivative of Camptothecin, in the Treatment of Advanced Non-Small-Cell Lung Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900229-9

7 January 2021

Phase I and pharmacologic study of topotecan: a novel topoisomerase I inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900229-9

7 January 2021

An activity from mammalian cells that untwists superhelical DNA--a possible swivel for DNA replication (polyoma-ethidium bromide-mouse-embryo cells-dye binding assay).

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900229-9

7 January 2021

Eukaryotic DNA topoisomerases: two forms of type I DNA topoisomerases from HeLa cell nuclei

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900229-9

7 January 2021

cDNA cloning of human DNA topoisomerase I: catalytic activity of a 67.7-kDa carboxyl-terminal fragment

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900229-9

7 January 2021

Roles of DNA topoisomerases in simian virus 40 DNA replication in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900229-9

7 January 2021

Supercoiling of the DNA template during transcription

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900229-9

7 January 2021

The basis for camptothecin enhancement of DNA breakage by eukaryotic topoisomerase I.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900229-9

7 January 2021

Characterization of an altered DNA catalysis of a camptothecin-resistant eukaryotic topoisomerase I.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900229-9

7 January 2021

Plant antitumor agents. 23. Synthesis and antileukemic activity of camptothecin analogues

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900229-9

7 January 2021

Plant antitumor agents. 25. Total synthesis and antileukemic activity of ring A substituted camptothecin analogues. Structure-activity correlations

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900229-9

7 January 2021

Plant antitumor agents. 22. Isolation of 11-hydroxycamptothecin from Camptotheca acuminata Decne: total synthesis and biological activity

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900229-9

7 January 2021

Plant antitumor agents. 18. Synthesis and biological activity of camptothecin analogues

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900229-9

7 January 2021

Plant antitumor agents. 30. Synthesis and structure activity of novel camptothecin analogs

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900229-9

7 January 2021

Antitumor activity of a new camptothecin derivative, SN-22, against various murine tumors.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900229-9

7 January 2021

Antitumor effect of CPT-11, a new derivative of camptothecin, against pleiotropic drug-resistant tumors in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900229-9

7 January 2021

Phase II study of CPT-11, a new camptothecin derivative, in metastatic colorectal cancer. CPT-11 Gastrointestinal Cancer Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900229-9

7 January 2021

Phase I and pharmacologic studies of the camptothecin analog irinotecan administered every 3 weeks in cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900229-9

7 January 2021

Phase I trial of low-dose continuous topotecan infusion in patients with cancer: an active and well-tolerated regimen

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900229-9

7 January 2021

Randomized phase II study of two schedules of topotecan in previously treated patients with ovarian cancer: a National Cancer Institute of Canada Clinical Trials Group study

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900229-9

7 January 2021

9-Aminocamptothecin and beyond. Preclinical and clinical studies

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900229-9

7 January 2021

Phase I and pharmacologic study of 9-aminocamptothecin given by 72-hour infusion in adult cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900229-9

7 January 2021

The current status of irinotecan (CPT-11) in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900229-9

7 January 2021

CPT-11. The European experience

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900229-9

7 January 2021

Clinical trials of irinotecan hydrochloride (CPT, campto injection, topotecin injection) in Japan

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900229-9

7 January 2021

Topotecan versus paclitaxel for the treatment of recurrent epithelial ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900229-9

7 January 2021

Clinical studies of topotecan

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900229-9

7 January 2021

Synthesis of water-soluble (aminoalkyl)camptothecin analogs: inhibition of topoisomerase I and antitumor activity

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900229-9

7 January 2021

10.1016/S0959-8049(98)00229-9

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9893620%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9893620%20AND%20SRC:MED&resulttype=core&format=json